Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas-Reference-Cited by-同舟云学术

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

Published:2007-01-24 Issue:1 Volume:83 Page:53-60
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Desjardins Annick,Quinn Jennifer A.,Vredenburgh James J.,Sathornsumetee Sith,Friedman Allan H.,Herndon James E.,McLendon Roger E.,Provenzale James M.,Rich Jeremy N.,Sampson John H.,Gururangan Sridharan,Dowell Jeannette M.,Salvado August,Friedman Henry S.,Reardon David A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-006-9302-2.pdf

Reference26 articles.

1. See SJ, Gilbert MR (2004) Anaplastic astrocytoma: diagnosis, prognosis, and management. Semin Oncol 31:618–634

2. Engelhard HH, Stelea A, Mundt A (2003) Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surg Neurol 60:443–456

3. Lonardi S, Tosoni A, Brandes AA (2005) Adjuvant chemotherapy in the treatment of high-grade gliomas. Cancer Treat Rev 31:79–89

4. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585–2597

5. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011–1018

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines;2024-06-30

2. Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic Review;The World Journal of Men's Health;2024

3. Precision Medicine Advancements in Glioblastoma: A Systematic Review;BioMedicine;2023-05-26

4. Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future;Current Oncology Reports;2023-03-28

5. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present;Biomolecules;2022-06-10